In addition, Chiperi et al. (97) recently published a systematic review on the use of biochemical biomarkers in pediatric CHD surgery: they reported poor predictive value of NSE and BDNF and conflicting results on S100B, but suggested GFAP as a possible biomarker for brain injury. The gene discussed is ENO2; the disease is coronary artery disorder.